Functional Target Validation for Alzheimer's Disease-Related Dementias
Funds phased research proving a newly identified Alzheimer's-related dementia target truly causes the disease process it's linked to.
About
A treatment can only be as good as the target it's aimed at, and right now the field has a shortage of well-validated ones. That is the barrier this notice is built to remove for Alzheimer's Disease-Related Dementias (ADRD) and other complex central nervous system disorders — translating a basic discovery into the clinic depends on how rigorously the target was validated, and on real confidence th…
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.